Hong Yang Haojing Li Yu Fang Zhijun Li Jianhua Zhu Huan Liu Chao Lu Xiaoyan Zhang Tonghui Ma Cuiying Zhang
10.3389/fmed.2022.979032
Front Med (Lausanne)
2022 Oct 6;9:979032.
5′ nok fusion alk nsclc rna ngs ensartinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/36275795/
Case Reports
PMC9582288
36275795
A non-functional 5' ALK fusion validated at the RNA level as a classical EML4-ALK that responds well to the novel ALK inhibitor ensartinib: A case report
2022